Alas, the latest revisions to the National Comprehensive Cancer Network (NCCN) guidelines on early detection of prostate cancer seem to have instigated more furore than they have clarity (although the original premise behind them may have been well intentioned). The new guidance was unveiled at the 19th Annual Conference of the NCCN, being held in Hollywood, Florida, […]![]()
